FDA D.I.S.C.O. Burst Edition: FDA approval of Tecartus (brexucabtagene autoleucel) for adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia
0:00
2:30
Listen to a soundcast of the October 1, 2021 FDA approval of Tecartus (brexucabtagene autoleucel) for adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia.
Mais episódios de "FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)"
Não percas um episódio de “FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)” e subscrevê-lo na aplicação GetPodcast.